Literature DB >> 11389514

Introduction to the Immunocompromised Host Society consensus conference on epidemiology, prevention, diagnosis, and management of infections in solid-organ transplant patients.

R H Rubin1, A Schaffner, R Speich.   

Abstract

Infectious complications are still a significant cause of morbidity and death in solid-organ transplant patients, with significant infection being found in up to two-thirds of these individuals. The risk of infection in the organ transplant patient, particularly of opportunistic infection, is largely determined by 3 factors: the net state of immunosuppression, the epidemiologic exposures the patient encounters, and the consequences of the invasive procedures to which the patient is subjected. The most important principles of patient treatment are prevention, early diagnosis, and specific therapy. This issue is designed as a position paper by a group of experts on epidemiology, prevention, diagnosis, and management of infections in solid-organ transplant patients. We feel that our efforts may serve as an important first step in the development of guidelines in this area.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11389514     DOI: 10.1086/320896

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  6 in total

1.  Importance of radiological detection of early pulmonary acute complications of liver transplantation: analysis of 259 cases.

Authors:  Elisabetta Panfili; Daniele Nicolini; Valentina Polverini; Andrea Agostini; Marco Vivarelli; Andrea Giovagnoni
Journal:  Radiol Med       Date:  2014-11-25       Impact factor: 3.469

2.  Human cytomegalovirus-specific T-cell immune reconstitution in preemptively treated heart transplant recipients identifies subjects at critical risk for infection.

Authors:  Davide Abate; Marta Fiscon; Alda Saldan; Simona Cofano; Carlo Mengoli; Dino Sgarabotto; Chiara d'Agostino; Luisa Barzon; Riccardo Cusinato; Giuseppe Toscano; Giuseppe Feltrin; Antonio Gambino; Gino Gerosa; Giorgio Palù
Journal:  J Clin Microbiol       Date:  2012-03-29       Impact factor: 5.948

3.  Nonhuman primate infections after organ transplantation.

Authors:  Silke V Haustein; Amanda J Kolterman; Jeffrey J Sundblad; John H Fechner; Stuart J Knechtle
Journal:  ILAR J       Date:  2008

4.  Use of hepatitis C-positive donors in transplantation.

Authors:  Edson Abdala; Luis Sérgio Fonseca de Azevedo; Silvia Vidal Campos; Marlova Luzzi Caramori; Sílvia Figueiredo Costa; Tania Mara Varejão Strabelli; Lígia Camera Pierrotti; Glaucia Fernanda Varkulja; Gisele Madeira Duboc de Almeida; Maria Aparecida Shikanai-Yasuda
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

5.  Assessment of organ transplants from donors with markers of hepatitis B.

Authors:  Edson Abdala; Luis Sérgio Fonseca de Azevedo; Vivian Iida Avelino-Silva; Sílvia Figueiredo Costa; Marlova Luzzi Caramori; Tania Mara Varejão Strabelli; Lígia Camera Pierrotti; Heloisa Helena de Souza Marques; Heloisa Helena Marques da Silva; Marta Heloisa Lopes; Glaucia Fernanda Varkulja; Vera Aparecida Santos; Maria Aparecida Shikanai-Yasuda
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

Review 6.  Infectious Complications in Lung Transplant Recipients.

Authors:  Polina Trachuk; Rachel Bartash; Mohammed Abbasi; Adam Keene
Journal:  Lung       Date:  2020-11-09       Impact factor: 2.584

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.